Bram de Kruijff

Bram de Kruijff is an executive leader in the biopharmaceutical industry with extensive experience spanning over two decades. Currently serving as the Executive Vice President and Site Director at Byondis since 2019, Bram plays a key role in advancing targeted medicines for cancer and autoimmune diseases alongside a team of highly skilled professionals. Prior to Byondis, Bram held various leadership positions at Synthon from 2004 to 2019, including Director of Global Strategic Projects and Site General Manager for multiple facilities, where responsibilities included managing strategic projects, leading site operations, and overseeing large-scale capital investments globally. Earlier career experiences include project management roles at Allergan, Astellas Pharma Europe, and Jacobs Engineering, with a focus on the pharmaceutical and chemical industries. Bram de Kruijff's educational background includes studies at The Wharton School and INSEAD, as well as degrees from the University of Bradford and NHL Hogeschool.